IL-33 Participates in the Development of Esophageal Adenocarcinoma

Background: The progression from chronic gastroesophageal reflux disease (GERD) to Barrett esophagus (BE) and esophageal adenocarcinoma (EAC) is an inflammatory-driven neoplastic change. Interleukin-33 (IL-33) has identified as a crucial factor in several inflammatory disorders and malignancies. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Liu, Lei, Su, Yang, Wang, Yi, Zhu, Yuchun, Sun, Xiaobin, Guo, Yuanbiao, Shan, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469785/
https://www.ncbi.nlm.nih.gov/pubmed/36110250
http://dx.doi.org/10.3389/pore.2022.1610474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469785/
https://www.ncbi.nlm.nih.gov/pubmed/36110250
http://dx.doi.org/10.3389/pore.2022.1610474

Ejemplares similares